Researchers have said that discontinuing hormone therapy may lead to decline in new breast cancer rates.
The study supports the hypothesis that stopping hormones can lead to tumour regression.
Breast Cancer Screening using Mammogram
Breast cancer if detected early can be completely cured. Mammography is used to screen women for breast cancer.
Advertisement
As part of the national Breast Cancer Surveillance Consortium, researchers studied 741,681 woman-years of data (with a median of 3.3 years per woman) on 163,490 women aged 50-79 who were Group Health Cooperative members and had no prior history of breast cancer.
"This is the first study to look over time at screening mammography use among individual women by their hormone therapy status linked with their breast cancer diagnoses," said lead author Diana S.M. Buist, PhD, a senior investigator at Group Health Research Institute.
![Male Breast Cancer]( "Male Breast Cancer")
Most cases of male breast cancer are diagnosed between the ages of 60 and 70 years. Treatment of male breast cancer often involves surgery.
Previous research has shown a rapid decline in new breast cancers-and also in use of hormone therapy and of screening mammography-since 2002, when the Women's Health Initiative published that breast cancer rates were higher in women taking estrogen and progestin than in those taking either a placebo or only estrogen.
Some have suggested that the decline in use of hormone therapy may have caused the fall in the breast cancer rate, perhaps by making tumors regress, Dr. Buist explained.
But others have countered that the explanation for the declines in both breast cancer and hormone use might instead be that because former hormone users are less concerned about breast cancer or see their doctors less often, they may get less screening mammography than do women who have never taken hormones.
"We set out to test this idea," Dr. Buist said, "and our results seem to refute it."
Before 2002, former users of hormone therapy had lower rates of screening mammography than did current users.
"But we found that this is no longer true," she said. Indeed, former users had the same or even slightly higher screening rates than current users.
"We concluded that differences in rates of screening mammography don't explain the declines in rates of the incidence of invasive breast cancer among women who've stopped using hormone therapy," Dr. Buist added.
The study has been e-published in Cancer Epidemiology, Biomarkers, 'n' Prevention.
Source: ANI
Male Breast Cancer
Most cases of male breast cancer are diagnosed between the ages of 60 and 70 years. Treatment of male breast cancer often involves surgery.
Advertisement
Previous research has shown a rapid decline in new breast cancers-and also in use of hormone therapy and of screening mammography-since 2002, when the Women's Health Initiative published that breast cancer rates were higher in women taking estrogen and progestin than in those taking either a placebo or only estrogen.
Some have suggested that the decline in use of hormone therapy may have caused the fall in the breast cancer rate, perhaps by making tumors regress, Dr. Buist explained.
But others have countered that the explanation for the declines in both breast cancer and hormone use might instead be that because former hormone users are less concerned about breast cancer or see their doctors less often, they may get less screening mammography than do women who have never taken hormones.
"We set out to test this idea," Dr. Buist said, "and our results seem to refute it."
Before 2002, former users of hormone therapy had lower rates of screening mammography than did current users.
"But we found that this is no longer true," she said. Indeed, former users had the same or even slightly higher screening rates than current users.
"We concluded that differences in rates of screening mammography don't explain the declines in rates of the incidence of invasive breast cancer among women who've stopped using hormone therapy," Dr. Buist added.
The study has been e-published in Cancer Epidemiology, Biomarkers, 'n' Prevention.
Source: ANI
Breast Cancer during Pregnancy
Management of breast cancer during pregnancy or pregnancy associated breast cancer requires special consideration to avoid harm to the fetus.
Advertisement
 Screening for Breast Cancer with Clinical Breast ExaminationClinical breast examination is a simple and inexpensive method of detecting breast cancer especially in women who do not have access to mammography. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
